Genome editing to model and reverse a prevalent mutation associated with myeloproliferative neoplasms. Baik R, Wyman SK, Kabir S, Corn JE, et al. PLoS One 2021;16:e0247858.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Baik R, Wyman SK, Kabir S, Corn JE, et al. Genome editing to model and reverse a prevalent mutation associated with myeloproliferative neoplasms. PLoS One 2021;16:e0247858.
PMID: 33661998